Paid Clinical Trials in Marietta, GA
As of August 2026, 93 paid clinical trials are recruiting in Marietta, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Marietta offers studies at sites including Wellstar Kennestone Hospital for conditions such as Hypertension, Cardiovascular Diseases, Intracerebral Hemorrhage, Major Depressive Disorder. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Marietta
Trials by drug in Marietta
Filter results
Newly added in Marietta
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
83 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
ELEVATE High-Risk PCI Pivotal Study
Global Paradise System US Post Approval Study
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Top Research Study Locations in Marietta
Researchers run research studies in Marietta, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Wellstar Kennestone Hospital | Acute Ischemic Stroke, Anatomic Stage IV Breast Cancer AJCC v8, Cardiovascular Diseases | 12 |
| Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital | Carcinoma, Non-Small-Cell Lung, Extensive-Stage Small Cell Lung Cancer, Follicular Lymphoma | 7 |
| Wellstar Health System | Aneurysmal Subarachnoid Hemorrhage (aSAH), Atrial Fibrillation, Postoperative, Cerebral Vasospasm | 5 |
| Wellstar Research Institute | Angina, Hypertension, Hypertension, Essential | 4 |
| Northwest Georgia Oncology Centers | Non-small Cell Lung Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer | 4 |
| Atlanta Research Center for Rheumatology | Arthritis, Psoriatic, Lupus Erythematosus, Systemic, Overweight or Obesity | 3 |
| Psych Atlanta | Depression, Depression - Major Depressive Disorder, Depression Disorder | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Drug Studies America | Acute Migraine, Migraine | 2 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis | 2 |
| Gastrointestinal Specialists of Georgia | C. Diff Infection, C.Difficile Diarrhea, CDI | 2 |
| Georgia Retina | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 2 |
| Marietta Eye Clinic | Geographic Atrophy, Juvenile Myopia, Macular Degeneration | 2 |
| Neurocrine Clinical Site | Tardive Dyskinesia, Bipolar Disorder, Major Depressive Disorder | 2 |
| Psych Atlanta, Pc | Major Depressive Disorder | 2 |
| Woolfson Eye Institute | Forme Fruste Keratoconus (FFK), Keratoconus, Down Syndrome (DS) | 2 |
| Investigational | Ulcerative Colitis, Crohn's Disease | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Alliance Spine and Pain Ctrs | Lumbar Spinal Stenosis | 1 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Emory at East Cobb - Primary Care | Early Detection of Cancer, Lung Cancer Screening, Lung Neoplasms | 1 |
| Gastrointestinal Specialists of Georgia PC | Chronic Idiopathic Constipation (CIC) | 1 |
| Gastrointestinal Specialists of Georgia, PC | Metabolic Dysfunction-associated Steatohepatitis | 1 |
| Georgia Institute for Clinical Research | Partial Thickness Rotator Cuff Tear | 1 |
| Georgia Retina - Marietta | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) | 1 |
Active & Upcoming Studies in Marietta (2026)
Recruiting trials in Marietta grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (23 active studies)
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma · Phase 3 · AbbVie
- Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) · University of California, Irvine
Cardiovascular (13 active studies)
- The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI · HeartFlow, Inc.
- BoxX-NoAF Clinical Trial · AtriCure, Inc.
Diabetes & metabolic (7 active studies)
- A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH · Phase 3 · GlaxoSmithKline
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Mental health & behavior (6 active studies)
- Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) · University of California, Irvine
- Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · Bristol-Myers Squibb
Neurology & pain (6 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Eye & vision (3 active studies)
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
Common conditions studied in Marietta
- Hypertension (4 active studies)
- Cardiovascular Diseases (3 active studies)
- Intracerebral Hemorrhage (3 active studies)
- Major Depressive Disorder (3 active studies)
- Acute Ischemic Stroke (2 active studies)
- Binge-Eating Disorder (2 active studies)
Leading research sponsors in Marietta
- AstraZeneca
- Bristol-Myers Squibb
- AbbVie
- Axsome Therapeutics, Inc.
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Marietta?
There are approximately 93 recruiting clinical trials in Marietta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Marietta pay participants?
Most recruiting trials in Marietta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Marietta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Marietta?
The most common conditions under active study in Marietta include Hypertension (4), Cardiovascular Diseases (3), Intracerebral Hemorrhage (3), Major Depressive Disorder (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Marietta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Marietta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Marietta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Marietta?
Recruiting research sites in Marietta include Wellstar Kennestone Hospital, Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital, Wellstar Health System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Marietta right now?
The largest active categories in Marietta are Cancer & tumors (23), Cardiovascular (13), Diabetes & metabolic (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.